Fibrinolysis and Proteolysis » Fibrinolytic Factors and Inhibitors

Abstract Number: PB0737

Carboxypeptidase U (CPU, TAFIa, CPB2) Generation in Acute Ischemic Stroke Patients Undergoing Thrombolysis and Endovascular Thrombectomy

J.C. Mertens¹, V. Blanc-Guillemaud², K. Claesen¹, D. Leenaerts¹, B. Tyl², P. Cardona³, D. Hendriks¹, C.A. Molina^4,5

Abstract Number: PB0749

Changes in Fibrinolytic Factors in a Simulated Extracorporeal Membrane Oxygenator Circuit

A. Doyle¹, N. Gooby², K. Parmar¹, K.A. Breen², N.A. Barrett², A. Retter², B.J. Hunt¹

Abstract Number: PB0748

Deep Mutational Scanning and High-Throughput Kinetics to Quantitatively Assess Plasminogen Activator Inhibitor-1 Variants

L.M. Haynes¹, Z.M. Huttinger¹, D. Ginsburg^1,2

Abstract Number: PB0753

Different Incorporation of Apha2-plasmin Inhibitor C-terminal Forms into the Fibrin Clot

B. Baráth, É. Katona

Abstract Number: PB0738

Dipicolinic Acid Produced by Fermentation (Bacillus subtilis natto)

H. Sumi¹, T. Mitsuo², H. Inoue³

Abstract Number: PB0751

Down-regulation of Plasminogen Activator Inhibitor-1 (PAI-1) by in vivo Thrombin Generation and Subsequent Formation of Activated Protein C (APC) in Carriers of the Factor V Leiden (FVL) and Prothrombin 20210G>A Mutation (PTM)

S. Reda, F.I. Winterhagen, C. Berens, J. Müller, J. Oldenburg, B. Pötzsch, H. Rühl

Abstract Number: PB0745

Downregulation of the Procarboxypeptidase U (proCPU, TAFI, proCPB2) System in ApoE^-/-Fbn1^C1039G+/- Mice Is a Non-Lipid Related Pleiotropic Effect of Statin Therapy

K. Claesen¹, K. Hermans¹, L. Roth², J.C. Mertens¹, I. De Meester¹, G.R.Y. De Meyer², D. Hendriks¹

Abstract Number: PB0736

Fibrinolytic Response Plays a Central Role in Trauma Induced Coagulopathy

H. Kwaan¹, M. Walsh²

Abstract Number: PB0742

HISTORY, an International Retrospective and Prospective Registry of Patients with Plasminogen Deficiency

A. Shapiro¹, M. Menegatti², R. Palla³, M. Boscarino², S. Siboni², M. Torres⁴, M. Batur⁵, R. Natesirinilkul⁶, C. Roberson¹, P. Lanzi⁷, J. Bowen⁸, N. Thukral¹, C. Nakar¹, F. Peyvandi^2,3

Abstract Number: PB0744

Hypercoagulability State in Iranian Patients with β-Thalassemia

S. Mohsenian¹, M. Zahedpanah^1,2, A. Azarkeivan¹, O. Seidi Zadeh¹

Abstract Number: PB0757

Low Fibrinolytic Activity Following Ischemia Reperfusion Is Not a Single Etiology: Fibrinolysis Shutdown versus Hypofibrinolysis

H. Moore¹, M. Cohen², C. Walker¹, T. Ferrell¹, E. Moore², A. Stem¹, J. Pomposelli¹, E. Pomfret¹, T. Nydam¹

Abstract Number: PB0741

Modulation of Thrombin Generation or Thrombin Activity on Activated Platelets Surface Largely Affected TAFI-Dependent Regulation of Fibrinolysis

Y. Suzuki, H. Sano, N. Honkura, T. Urano

Abstract Number: PB0739

Nattokinase – Inhibition of Melanin Synthesis (Whitening Effect)

H. Sumi¹, Y. Yanagisawa², S. Naito¹, C. Yatagai¹

Abstract Number: PB0747

Online Apps Improve Haemostasis Assay Reproducibility and Facilitate Open Data and Code Sharing

C. Longstaff, M. Locke

Abstract Number: PB0743

Polyphosphate Nanoparticles Are More Potent Stabilizers of Fibrin than Linear Polyphosphates and Histones Enhance their Effect

M. Lovas, A. Tanka-Salamon, L. Szabó, K. Kolev

Abstract Number: PB0754

Production of Nanobodies Targeting Plasminogen and Plasmin

E.M. Klein¹, N. Shahidi Hamedani¹, J. Müller¹, H. Rühl¹, P.A. König², J. Oldenburg¹, B. Pötzsch¹

Abstract Number: PB0755

Targeted Measurement of Plasmin Kinetics on the Activated Platelet Membrane

M. Simpson, B. Veuskens, C.S. Whyte, N.J. Mutch

Abstract Number: PB0756

The Influence of Prothrombin Complex Concentrates on Clot Stability

C.D. Garcia, P. Chowdary, M.R. Peralta, Z. Hanif, A. Riddell, P. Lawler, L. Dailani, C. Hamid

Abstract Number: PB0746

To Evaluate the Effect of Hydroxyurea on Blood Coagulation and Endothelial Activation in Sickle Cell Disease

M. Borhany, M. Abid, S. Zafar, T. Shamsi

Abstract Number: PB0752

Total and C-terminally Truncated Alpha2-plasmin Inhibitor Levels in Venous Thrombosis

É. Katona, B. Baráth, T. Miklós, D. Pituk, V. Fedoriska, L. Muszbek, Z. Bereczky